MeSH D013921 - thrombocytopenia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001791:Blood platelet disorders
0 Companies
0 Drugs
Success rate
D000095542:Cytopenia
0 Companies
0 Drugs
Success rate
D013921:Â
Thrombocytopenia
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Argatroban | Argatroban |  | 2014-12-15 |  |  |
| Prednisolone | Prednisolone |  | 1999-05-28 |  |  | |
| Prednisolone | Prelone |  | 1986-02-04 |  |  | |
| Taro Pharmaceutical | Prednisolone | Flo-pred | 2028-10-11 | 2008-01-17 |  |  |
| Mylan | Argatroban | Argatroban |  | 2014-06-30 |  |  |
| Roche | Ribavirin, Peginterferon alfa-2a | Pegasys Copegus |  | 2004-06-04 |  |  |
| Interferon alfa-2a | Roferon-A |  | 1986-06-04 |  |  | |
| Cipla | Argatroban | Argatroban | 2027-09-26 | 2011-06-29 |  |  |
| Sandoz | Argatroban | Argatroban |  | 2000-06-30 |  |  |
| Prednisolone | Omnipred |  | 1982-01-01 |  |  | |
| Genus Lifesciences | Prednisolone, Sulfacetamide | Sulfacetamide Prednisolone |  | 1993-05-27 |  |  |
1
2
3
4
5
6
...
8
>
Clinical Trials
Historical Success Rate
Phase 1
79%26/33
Phase 2
16%11/67
Phase 3
65%22/34
Approved: 15Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use